-
of concern in the UK emerge, spread, and unequally affect different individuals and population groups. Outcomes of this research will help advance the development of more equitable, spatial data-driven
-
expertise, including facilities for high-throughput screening and high content imaging, multimodality in vivo imaging, proteomics, spatial and single-cell transcriptomics. As part of King’s Health Partners
-
high content imaging, multimodality in vivo imaging, proteomics, spatial and single-cell transcriptomics. As part of King’s Health Partners, we have an excellent environment for basic-clinical
-
transplant rejection through cutting-edge spatial multi-omics and computational metabolic modeling. The role involves developing and implementing computational methods to integrate single-cell and spatial